Skip to content

News Releases

 
News Releases
  Date Title and Summary View
May 5, 2018
TITUSVILLE, N.J., May 5, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the results from two Phase 3 clinical studies of the investigational compound esketamine nasal spray in patients with treatment-resistant depression. These studies will be presented at the American Psychiatric Association Annual M...
May 3, 2018
NEW BRUNSWICK, N.J., May 3, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the 2018 UBS Global Health Care Conference on Monday, May 21st, at the Grand Hyatt, New York.   Sandi Peterson, Executive Vice President, Group Worldwide Chairman will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time). This w...
May 2, 2018
NEW BRUNSWICK, N.J., May 2, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a review of its Consumer and Medical Devices businesses for the investment community beginning with a continental breakfast and access to exhibits at 8:00 a.m. (Eastern Time) on Wednesday, May 16, 2018 at the Hyatt Regency Hotel in New Brunswick, New Jersey, an...
Apr 30, 2018
Apr 26, 2018
NEW BRUNSWICK, N.J., April 26, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 7.1% increase in the quarterly dividend rate, from $0.84 per share to $0.90 per share.  The increase was announced this morning at the Annual Meeting of Shareholders in New Brunswick, N.J. "In recogniti...
Apr 24, 2018
NEW BRUNSWICK, N.J., April 24, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the 2018 Deutsche Bank 43rd Annual Health Care Conference on Wednesday, May 9th, at The InterContinental Boston.  Mathai Mammen, MD, Ph.D., Global Head, Research & Development, Janssen Research and Development will represent the Company in a sessio...
Apr 17, 2018
NEW BRUNSWICK, N.J., April 17, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced sales of $20.0 billion for the first quarter of 2018, an increase of 12.6% as compared to the first quarter of 2017. Operational sales results increased 8.4% and the positive impact of currency was 4.2%. Domestic sales increased 6.1%. International sal...
Apr 16, 2018
Apr 12, 2018
Apr 11, 2018
JACKSONVILLE, Fla., April 11, 2018 /PRNewswire/ -- Johnson & Johnson Vision today announced ACUVUE OASYS® with Transitions® Light Intelligent Technology™ first of its kind contact lens that provides wearers with vision correction and a dynamic photochromic filter that helps to continuously balance the amount of light entering the ey...
Page: FirstPrevious
3
... NextLast
= add release to Briefcase